Answers are grounded in this paper and cite their sources.
Phase II trial shows efficacy of ivonescimab with chemotherapy in advanced biliary tract cancer, suggesting improved outcomes.
Ivonescimab combined with gemcitabine and cisplatin as first-line therapy for advanced biliary tract cancer: phase II trial results
No takes yet. Share an insight, caveat, or question.
吴逵(Kui Wu) (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: